SHWZ
Medicine Man Technologies Inc
Price:  
0.02 
USD
Volume:  
6,750.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SHWZ WACC - Weighted Average Cost of Capital

The WACC of Medicine Man Technologies Inc (SHWZ) is 19.2%.

The Cost of Equity of Medicine Man Technologies Inc (SHWZ) is 192.85%.
The Cost of Debt of Medicine Man Technologies Inc (SHWZ) is 23.90%.

Range Selected
Cost of equity 132.70% - 253.00% 192.85%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 23.90% - 23.90% 23.90%
WACC 18.7% - 19.7% 19.2%
WACC

SHWZ WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 28.01 44.3
Additional risk adjustments 0.0% 0.5%
Cost of equity 132.70% 253.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 100.2 100.2
Cost of debt 23.90% 23.90%
After-tax WACC 18.7% 19.7%
Selected WACC 19.2%

SHWZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SHWZ:

cost_of_equity (192.85%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (28.01) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.